In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist class for the treatment of type 2 diabetes”,” funded from the state budget by the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., requested to submit a bid for the purchase and supply of the reference product Ozempic.
Details of the price inquiry can be found in the documents attached below.